Implantation of marker seeds into the prostate; to improve quality of radiotherapy delivery and to allow dose escalation for men with localised prostate cancer
Completed
- Conditions
- ocalised prostate cancer in men.Inter-fraction prostate motion and motion of prostate relative to its position at simulation are potential sources of systematic treatment error.Localised prostate cancer in men.Inter-fraction prostate motion and motion of prostate relative to its position at simulation are potential sources of systematic treatment error.Cancer - Prostate
- Registration Number
- ACTRN12607000335493
- Lead Sponsor
- Dr George Hruby
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
all men with clinically localised prostate cancer consented for radiotherapy
Exclusion Criteria
on anti-coagulants where ceasing the medications are a cardiovascular risk
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the feasibility and potential implications for using fiducial markers rather than bony landmarks for realigning patients during treatment.<br>Every patient will have 7 weeks of radiation therapy treatment. During treatment, they will have daily portal films for the first 2 weeks and then twice per week for the remaining weeks. Measurements of the seeds position will be performed by a medical physicist.[The feasibility outcome will be analysed after 20 patients' fiducial markers measurements have been collected.]
- Secondary Outcome Measures
Name Time Method